Home > Category > Signaling Pathways > Antibody-drug Conjugate/ADC Related > Drug-Linker Conjugates for ADC > Anti-Trop2 (sacituzumab govitecan biosimilar) mAb

Anti-Trop2 (sacituzumab govitecan biosimilar) mAb

ChemLeader 98+%
Catalog No:CLA1052 CAS No.:1491917-83-9 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $1200.00 Visible after login
- +
5 mg 3-5days $3300.00 Visible after login
- +
10 mg 3-5days $5500.00 Visible after login
- +
50 mg 3-5days $22000.00 Visible after login
- +
100 mg 3-5days $42000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Anti-Trop2 (sacituzumab govitecan biosimilar) mAb
CAS1491917-83-9
Storage conditionStore at 4°C, do not freeze
Product details

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays